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Background: Immortal cell lines and cell lines derived from operative specimens 
transplanted into animal models are used in meningioma research. We address two 
criticisms of the mouse xenograft flank tumor model: Why are tumor induction rates 
derived from operative specimens low and inconsistent? Are flank tumors 
meningiomas?
Methods: Meningioma cell cultures were processed for Giemsa-band karyotyping and 
flow cytometry. Mouse flank tumors induced subcutaneously were analyzed 
microscopically, immunohistochemically, and ultrastructurally. G-band studies identified 
meningiomas with simple karyotype (< 1 chromosomal abnormality) or complex 
karyotype (multiple chromosomal abnormalities).
Results: Cell cultures with complex karyotypes (lOMM-Lee, CH-157 MN, 2 operative 
specimens) grew rapidly in vitro and induced tumors in 49/50 (98%) animals. 
Meningioma cell cultures with simple karyotypes grew slowly in vitro and showed small, 
non-growing tumors in mouse flanks (10/10). Meningioma flank tumors were vimentin 
positive with ultrastructural features consistent with meningiomas. Cell cultures with 
complex karyotypes grew faster in cell culture and consistently induced flank tumors, 
unlike meningiomas with simple karyotypes.
Conclusions: Meningioma cell lines transplanted into flanks of nude mice exhibit 
microscopic, immunohistochemical, and ultrastructural features of meningiomas. The 
ease of monitoring tumor growth in the subcutaneous mouse flank model is its primary 
advantage, although we recognize an intracranial location is more biologically desirable.
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Meningiomas are slow-growing, benign tumors that arise from the central 
nervous system meninges [2]. Specialized meningothelial cells called arachnoid cap 
cells are the cells of origin of meningiomas. These cells are most common within the 
arachnoid villi but may be present throughout the craniospinal arachnoid space. 
Meningiomas account for approximately 20% of all primary adult intracranial tumors. 
They are more common in women (2:1) and generally occur in older patients. 
Meningiomas are graded as benign (approximately 91% of meningiomas), atypical 
(5%), and anaplastic/malignant (4%) [10, 22]. The grading of meningiomas takes into 
account both the tumor subtypes known to have a higher rate of recurrence and specific 
histologic features suggesting a more aggressive biology [6, 21]. Although most 
meningiomas can now be removed safely, their intrinsic biology and location are still the 
main determinants of the overall outcome of the patient [6, 21, 35].
The study of meningioma biology and possible treatment regimes involves in vitro 
and in vivo studies on immortal cell lines, as well as cell lines derived from operative 
specimens [14, 18, 36, 37], Cell culture experiments are not necessarily a reflection of in 
vivo responses, so meningioma animal models were developed [25]. Transplantation of 
human meningiomas into guinea pig eyes was first described in 1945 [11 ]. Since that 
time, several xenograft animal transplantation models have been described to include 
the chorioallantoic membrane of the duck and chick, and the subcutis, subrenal capsule, 
flank, brain, and skull base of athymic mice [23-26, 30, 38, 40]. Obviously, the 
intracranial model is the most biologically desirable, but it is limited by the difficulty in 
obtaining direct serial measurements. The subrenal capsule has high tumor induction
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rates, but transplantation to this location is technically challenging and does not allow for 
direct serial measurements. Flank models were initially limited by low tumor induction 
rates until Matrigel augmentation was first described by our laboratory in 1998 [13, 15]. 
Initially, Matrigel augmentation was noted to induce tumors in 100% of mouse flanks, but 
this initial report was optimistic and our experience over the last 8 years places tumor 
induction closer to 60% (R.L. Jensen, personal observation) [13]. Furthermore, other 
investigators have not been able to replicate our tumor induction rates (R.L. Jensen, 
personal observation).
The purpose of this manuscript was to analyze our meningioma mouse flank 
tumor model to address two long-held criticisms: 1. Why are tumor induction rates so 
poor in animals injected with cell lines derived from operative specimens? 2. Are mouse 
flank tumors meningiomas? We reviewed our laboratory experience over the past three 
years with two immortal meningioma cell lines and cells derived from operative 
specimens in an attempt to address these criticisms.
MATERIALS AND METHODS
Analysis of Our Experience with the Meningioma Mouse Flank Model
Over the last three years our laboratory has used the mouse meningoma flank 
model to study the effects of various therapies on tumor growth (data not shown). The 
following report represents the control data from these in vitro and in vivo experiments. 
Consequently, not all operative specimens grown in vitro were processed for all 
experiments or implanted into the flanks of mice for in vivo studies.
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Meningioma surgical specimens were obtained under a University of Utah 
Institutional Review Board (IRB) protocol and processed for immunohistochemistry and 
cell culture as described below. Tumors were graded according to World Health 
Organization criteria [21]. Patient data for in vitro and in vivo studies are listed in Table 
1. In this paper, we will use the term “benign meningioma” to describe a WHO grade I 
meningioma and “primary cell line” to refer to newly established cell lines established 
from operative samples [21].
Meningioma Cell Culture
Tumor specimens were obtained from patients harboring meningiomas and 
grown as monolayer as described previously [12, 14]. Briefly, operative specimens were 
taken immediately from the operating room, digested in collagenase, and placed in 
Dulbecco’s Modified Eagle Medium (DMEM) (Sigma) supplemented with 10% fetal calf 
serum, L-glutamine (2 |aM), penicillin (50 lU/mL), and streptomycin (50 mg/ml_).
Cultured cells were maintained at 37°C in 7.5% CO2 . Only passages 1-5 were used in 
experiments for this study.
The human immortal cell lines lOMM-Lee and CH-157 MN were also grown in 
DMEM supplemented with 10% fetal calf serum, L-glutamine (2 |aM), penicillin (50 
lU/mL), and streptomycin (50 mg/ml_) at 37 °C in 7.5% CO2 [18, 36]. The lOMM-Lee and 
CH-157 MN cell lines were kind gifts from Dr. Ian McCutcheon (University of Texas,
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M.D. Anderson Cancer Center, Houston, Texas) and Dr. Yancey Gillespie (University of 
Alabama School of Medicine, Birmingham, Alabama), respectively.
Karyotyping: G-Band Chromosome Analysis
The meningioma cell lines were grown in T-175 flasks to confluence and 
processed by the cytogenetics core facility at the University of Utah for Giemsa-band 
chromosome analysis.
Cell Counts by Bright-line Hemocytometer
Cell lines were plated into 6 well plates at a density of 1x104 or 1x105per well.
Cell counts were accomplished each day (days 1-14) by harvesting the cells with 
trypsin and counting them using a bright-line hemocytometer. Cells in two wells were 
counted for each time point and two counts were done per well for a total of four counts 
per time point. Doubling times were calculated during logarithmic growth.
Fluorescent Activated Cell Sorting (FACS) for Cell-Cycle Phase
lOMM-Lee, CH-157 MN, and meningioma cell lines derived from operative 
specimens were plated in T-175 flasks (immortal cell lines 1x106 cells per flask and 
operative cell lines 1x107 cells per flask) at 30% confluence and allowed to grow for 24 
hours to ensure logarithmic growth. Cells were harvested using Accutase (MP 
Biomedicals, Irvine, CA) and declumped by drawing them through a 26-gauge needle 
five times. Cells (1x107) were resuspended in 1 mL of ice-cold Dulbecco's phosphate- 
buffered saline (DPBS) and fixed by adding 2 mL of ice-cold methanol, then stored at
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4°C for at least 2 hours. Cells are then rehydrated for 5 minutes in DPBS on ice and 
stained in 1 mL of DPBS/propidium iodide solution (50 |jg/ml propidium iodide, 200 
|jg/ml RNase A, 0.1% Triton X-100) for 30 minutes in the dark at room temperature. The 
cells were sorted within 5 hours of staining by FACScan Analyzer (Becton-Dickinson, 
Franklin lakes, NJ) and results were analyzed using CellQuest (Becton-Dickinson).
Mouse Xenograft Flank Model: Transplanting and Harvesting Tumors
Cells were grown to confluence in T-175 flasks. All steps were carried out on ice. 
T-175 flasks were rinsed with PBS, trypsinized, counted, and pelleted at 1000 rpm for 5 
minutes at 4QC. Excess medium was removed and the pellet was resuspended in 
medium to obtain between 5.0x105 and 1.5x106 cells per mL for the lOMM-Lee cell line, 
between 1.0x106 and 1.25x106 cells per mL for the CH-157 MN cell line, and as many 
cells as were present in a T-175 flask for primary meningioma cell lines (cell counts for 
patients #3, #4, #5, and #6 are 1.6x107, 1.1x107, 1.0x105, and 1.7x106 cells per flank, 
respectively). One-milliliter aliquots were placed in 2-mL microtubes and spun at 1,000 
rpm for 5 minutes at 4QC. Excess media was removed and the tumor cells were 
resuspended and aspirated into 1-cc tuberculin syringes. For the lOMM-Lee and CH- 
157 MN cell lines, 0.5 mL of media was used to resuspend the pellet before aspiration 
into the tuberculin syringe. For primary meningioma cell lines, 0.5 mL of Matrigel (B.D. 
Biosciences, Bedford, MA) was used to resuspend the pellet before aspiration into the 
tuberculin syringe. Tumor cells were injected subcutaneously into the flanks of 3-week- 
old immunodeficient mice (CD1, Charles River Laboratories, Wilmington, MA) using a 
25-gauge needle. A total of 20 mice were injected with the lOMM-Lee cell line (5 mice x
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4 experiments) and 10 mice with the CH-157 MN cell line (5 mice x 2 experiments). Five 
animals each were injected with cell lines derived from patients #3, #4, #5, and #6. 
Biweekly caliper measurements are started 10-14 days after injection to give time for 
the media or Matrigel to resorb completely.
Mice were sacrificed with a lethal intraperitoneal injection of pentobarbital. Flank 
tumors were excised, cut into blocks, and placed in 10% formalin for paraffin blocks or 
in 2.5% paraldehyde and 1% glutaraldehyde for electron microscopy.
Survival Analysis
Survival curves were graphed by analyzing the number of mice surviving until 
sacrifice (Comparison of Survival Curves, GraphPad Prism 4.0, San Diego, CA).
Animals were sacrificed because of large tumor size.
Immunohistochemical Staining for Vimentin, Epithelial Membrane Antigen (EMA), Glial 
Fibrillary Acidic Protein (GFAP), and MIB-1
Immunohistochemical stainings were performed by ARUP Laboratories (Salt 
Lake City, Utah). Briefly, slides were cut at 4 microns, then melted at 55-60°C for 30 
minutes, deparaffinized in xylene for 5 minutes, and rehydrated in graded alcohols 
(100% x 2, 95% x 2, 70% x 1) for 1 minute each. The following steps were performed on 
the Ventana ES (Ventana Medical Systems, Tucson, AZ) at 40°C. Heat-induced epitope 
retrieval was applied in citrate buffer (pH 6.0) in a microwave oven for 15 minutes at half 
power and allowed to cool for 15 minutes for tissue stained for vimentin, EMA, and 
GFAP. For the MIB-1 immunohistochemical staining, heat-induced epitope retrieval was
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applied in citrate buffer (pH 6.0) in an electric pressure cooker for 3 minutes and 
allowed to cool for 27 minutes. The primary antibodies were applied for 32 minutes 
[Vimentin (1:300, mouse monoclonal Ab, Clone Vim 3B4, Dako Cytomation,
Carpinteria, CA), EMA (1:200, mouse monoclonal Ab, Clone E29, Dako Cytomation), 
GFAP (1:400, mouse monoclonal Ab, Clone 6F2, Dako Cytomation), Ki-67 (1:100, 
mouse monoclonal Ab, Clone MIB-1, Dako Cytomation), Factor 8 (1:1600, rabbit 
polyclonal Ab, Dako Cytomation)] followed by the appropriate secondary antibody for 8 
minutes [Human Tissue: Goat anti-mouse/anti-rabbit (1:300, Rabbit Fab, Dako 
Cytomation); Mouse Tissue: Mouse Fab (1:200, Mouse IgG, Dako Cytomation)]. 
Detection was done using the IView DAB detection kit (Ventana) and the counterstain 
was done with Hematoxylin (Ventana) for 4 minutes. Slides were then dehydrated 
through graded alcohols (70% x 1, 95% x 2, 100% x 2) for 30 seconds each, dipped in 4 
changes of xylene, and covered with a coverslip. Positive controls consisted of normal 
uterus, normal pancreas, pancreas tumor, and normal tonsil for vimentin, EMA, MIB-1 
and factor 8, respectively. Negative controls were accomplished by running the above 
positive control tissue without the primary antibody.
MIB-1 1mmunohistochemical Analysis
Analysis of MIB-1 staining was performed by taking 6 random pictures per slide 
at 400X (10 ocular x 40 objective) using an Olympus Microfire camera. The images 
were analyzed using the Image-Pro Plus 5.0 graphic analysis program (Media 
Cybernetics, Silver Spring, MD). Results were reported as number of MIB-1 cells 
positive per 40x high-powered-field (hpf) and represent the mean (±S.D.) of 6 random
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fields per slide. Two slides were analyzed per original operative sample (i.e., 12 total 
data points). For meningioma flank tumors one slide was analyzed per animal, three 
animals per group (i.e., 18 total data points).
Transmission Electron Microscopy (TEM)
Operative and mouse tumor samples were harvested, cut into 1-mm3 blocks, and 
fixed in 2.5% paraformaldehyde with 1% glutaraldehyde. Cell culture meningiomas were 
grown to confluence in T-175 flasks, rinsed with PBS, scraped, pelleted, and fixed in 
2.5% paraformaldehyde with 1% glutaraldehyde. After at least 24 hours of fixation, 
samples were rinsed twice for 10 minutes each, in 0.1 M sodium cacodylate buffer with 
sucrose and calcium chloride at pH 7.4. This was followed by post-fixing in 2% osmium 
tetroxide in 0.1 M sodium cacodylate buffer for 45 minutes at room temperature on a 
rotator. Samples were then rinsed in distilled water for 5 minutes and stained en bloc in 
aqueous uranyl acetate for 45 minutes at room temperature on a rotator. Samples were 
then dehydrated with increasing alcohol concentrations (50%-100%) at room 
temperature on a rotator. Cells were then infiltrated with and then embedded in Spurr's 
plastic. Thin sections were cut on a Leica UCT Ultramicrotome with a Diatome diamond 
knife, stained with uranyl acetate and Reynolds’s lead citrate, and examined on a 
Hitachi H 7100 TEM at 75 KV. Photographs were taken on Kodak 4489 film.
RESULTS
Meningioma Characteristics
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Tumors were taken from 9 patients for establishment of primary cell cultures and 
the immortal cell lines lOMM-Lee and CH-157 for a total of 11 cell cultures. Of these 11 
patients, 73% were women; the age range of the patients was from 38 to 71 years with 
a median of 53 years (Table 1) [18, 36]. Intracranial meningoma location in the patients 
varied, as did the meningoma subtypes (although 6 were benign transitional tumors) 
(Table 1).
G-Band Karyotyping
Giemsa-band karyotyping was achieved on both immortal cell lines and six 
primary meningioma cell lines (Table 1). G-band analysis exhibited three general 
karyotypes: normal, a single chromosomal abnormality, or multiple chromosomal 
abnormalities. We grouped these further into simple and complex chromosomal 
karyotypes. Simple karyotypes were defined as normal or only one chromosomal 
abnormality, whereas complex karyotypes were meningiomas exhibiting multiple 
chromosomal abnormalities (Figure 1). Karyotyping of the lOMM-Lee cell line showed a 
complex karyotype with multiple chromosomal abnormalities fitting its initial description 
in 1990 (Table 1) [18]. The CH-157 MN cell line also exhibited a complex karyotype 
(Table 1). Both immortal cell lines showed additions to chromosomes 2, 5, 12, and 14 
with loss of chromosome 17 (Table 1). Complex karyotypes were also seen in patients 
3, 4, and 8, with similar chromosomal abnormalities noted on chromosomes 4, 5, 6, 9, 
and 12 (Table 1). Simple karyotypes were seen with patient 6 (monosomy 22, Table 1) 
and patients 5 and 7 (normal karyotypes, Table 1).
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In vitro Growth Rates
The in vitro growth rates of 6 cell lines were analyzed. Immortal meningioma cell 
lines showed the fastest in vitro growth rates, with doubling times of 20 and 23 hours, 
for lOMM-Lee and CH-157 MN cell lines, respectively (Figure 2). Meningiomas 
cultivated from operative specimens were noted to fall into fast- and slow-growing 
groups (Figure 2). Fast-growing cell lines were derived from patients 3 and 4, with 
doubling times of 40 and 65 hours, respectively (Figure 2). Slower-growing cell lines 
were obtained from patients 5 and 7, with doubling times of -120 hours (Figure 2). 
Interestingly, faster-growing cell lines had complex karyotypes (lOMM-Lee, CH-157 MN, 
patients 3 and 4), whereas slower-growing cell lines were derived from cell cultures 
exhibiting a simple karyotype (i.e., patients 5 and 7). Unlike the immortal cell lines, all 
cell lines cultivated from our operative specimens showed contact inhibition, slowing 
their growth rates as they reached confluence. Plating efficiency for the immortal cell 
lines was greater than 90%, whereas plating efficiency of cell lines obtained from 
operative specimens ranged from 40-90% and was dependent on trypsinization times; 
improved plating efficiency was seen with lower trypsin times.
FACS for Cel I-Cycle Phase
Flow cytometry for cell cycle characteristics was obtained on 7 cell lines growing 
logarithmically in vitro (lOMM-Lee, CH-157 MN, patients 4, 5, 8, 9, and 11) (Figure 3). 
The mean (±S.D.) percentage of lOMM-Lee cells in gap 1 (G1), synthesis (S) and gap 2 
(G2) was 40%±3%, 37%±8%, and 23%±7%, respectively. The CH-157 MN cell line
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exhibited 58%±5%, 38%±2%, and 4%±3% of cells in G1, S, and G2 phase, 
respectively.
The cell lines derived from operative specimens showed between 44% and 62% 
of cells in G1, 17% to 32% of cells in S, and 11 % to 39% of cells in G2. Overall, the 
immortal cell lines lOMM-Lee and CH-157 MN showed greater than 35% percent of 
cells in S phase, whereas the percentage of cells in S phase of operative cell cultures 
was lower (Figure 3).
Mouse Flank Tumor Growth Rates and Survival Proportions
A total of six cell lines were implanted into the flanks of nude mice, four cell lines 
with a complex karyotype (lOMM-Lee, CH-157 MN, patients 3 and 4) and two cell lines 
with a simple karyotype (patients 5 and 6) (Figure 4). The lOMM-Lee cell line induced 
flank tumors in 95% (19/20) of animals after subcutaneous injection of 5.5x105-1 .4x106 
cells per flank. Four of 20 (20%) animals died from tumor involvement. At autopsy, all 
four animals showed severe abdominal ascites with tumors invading through the 
abdominal peritoneum. Large organ metastases (e.g., lung, liver, kidney, and intestines) 
were not noted. Animal death was believed to be from compromise of the abdominal 
peritoneum with weeping of serous fluid into the abdominal cavity. All animals were 
sacrificed at 56 days because of tumor size. Mean tumor volumes (mm3) (±S.D.) at 15,
29, 43, and 56 days were 457 ± 347 mm3, 1228 ± 782 mm3, 2353 ± 1258 mm3, and 
4593 ± 1377 mm3, respectively (Figure 4).
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The CH-157 MN cell line induced flank tumors in 100% (10/10) of animals after 
subcutaneous injection of 1.1x106-1 .2x106 cells per flank. All animals survived to 43 
days and were sacrificed because of tumor size per animal protocol. Mean tumor 
volumes (mm3) (±S.D.) at 15, 29, and 43 days were 82 ± 46 mm3, 819 ± 654 mm3, and 
3196 ± 2574 mm3, respectively (Figure 4).
Two complex karyotype meningioma cell lines (Patients 3 and 4) showed 
excellent flank tumor induction and growth. The cell line from patient 3 induced tumors 
in 100% (5/5) of animals after subcutaneous injection of 1.6x107 cells per animal flank, 
with Matrigel. All mice survived. Animals were sacrificed at 35 days because of tumor 
size per animal protocol. Mean tumor volumes (±S.D.) at 14, 24, and 35 days were 
3038 ± 800 mm3, 5304 ± 1343 mm3, and 7473 ± 2694 mm3, respectively (Figure 4). The 
cell line derived from patient 4 also induced tumors in 100% (5/5) of animals after 
subcutaneous injection of 1.1x107 cells per animal flank. One animal died at 28 days 
because of tumor involvement. At autopsy, significant abdominal ascites was noted with 
tumor invading through the abdominal peritoneum. No metastasis of large organs (e.g., 
lung, liver, colon, or kidney) was noted. The cause of death was presumed to be similar 
to that it the lOMM-Lee animals, with serous exudate of the tumor into the abdominal 
cavity. Animals were sacrificed at 35 days because of tumor size, per animal protocol. 
Mean tumor volumes (±S.D.) at 14, 24, and 35 days were 2080 ± 872 mm3, 3053 ±
1260 mm3, and 5588 ± 3405 mm3, respectively (Figure 4).
Two simple karyotype meningioma cell lines (patient 5 and 6) were transplanted 
into mice and followed for a period of 2-3 months, during which the implanted tumors 
which did not grow (i.e., small tumors without growth). Flank tumors incited from simple
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karyotypes showed tumor take, but no significant growth after injection of 1.0x105 cells 
and 1.7x106 cells per flank for patients 5 and 6, respectively. Histologic analysis of flank 
tumors from patient 6 showed meningoma tumor cells (see below).. All mice survived. 
Animals were sacrificed at 96 days and 51 days for lack of tumor growth from patients 5 
and 6, respectively (Figure 4).
Mouse Flank Tumor Histology and Immunohistochemical Staining Results
Mouse flank tumors were processed for hematoxylin and eosin (H&E) staining, 
as well as immunohistochemically for GFAP, vimentin, EMA, and MIB-1. Both immortal 
cell lines showed hypercellular sheets without whorl formation and stained positive for 
vimentin, negative for GFAP, and weakly positive for EMA (Table 2, Figure 5). These 
flank tumors exhibited a high number of MIB-1-positive cells (Figure 5). The lOMM-Lee 
tumor invaded soft tissue, whereas the CH-157 MN cell line did not, but both exhibited a 
central core of necrosis.
Flank tumors induced by meningiomas with complex karyotypes (patients 3 and 
4) induced large tumors that showed lobular growth patterns with prominent nuclei, 
resembling their original operative specimens on H&E staining (Figure 5). The tumor 
induced by meningiomas from patient 3 showed features of a meningothelial 
meningoma in both the operative and flank tumor specimen (data not shown). 
Immunohistochemically, the tumors induced from the meningiomas in patients 3 and 4 
showed similar results when operative specimens were compared with their 
corresponding flank tumor: they were GFAP negative, vimentin positive, with weak EMA
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staining (Table 2, Figure 5). MIB-1 stainings of the operative samples showed 
significant proliferative rates.
Mouse flank tumors grown from meningioma cell cultures with a simple karyotype 
(patients 5 and 6) showed no significant tumor growth (i.e., non-growing tumors). 
Histologic analysis of the non-growing tumors from patient 6 showed the characteristic 
whorls and cell rests of a transitional meningioma, unlike the original operative 
specimen, which exhibited fibrous meningoma features of parallel spindle cells with 
wide fascicles (Figure 5). The operative MIB-1 staining showed many positive cells, 
whereas none were observed in the flank tumor sample. Moderate and weak vimentin 
immunostaining was noted in the operative and flank tumor specimens.
MIB-1 Counts
MIB-1 immunohistochemical staining data represents the mean number of 
positive cells per high-powered-field (hpf) ±S.D. (Figure 6). The original operative 
specimens for the immortal cell lines were unavailable for analysis. The two operative 
specimens that induced mouse flank tumors showed MIB-1 counts of 5.7 ± 4.1 and 1.1 
±1.1 for patients 3 and 4, respectively. The two operative specimens that showed tumor 
regression showed MIB-1 counts of 1.9 ± 1.3 and 13.6 ± 6.8, for patients 5 and 6, 
respectively. Analysis of cell lines inciting meningoma flank tumors showed MIB-1 
counts of -200 per hpf (211.0 ± 75.7, 190.6 ± 23.8, 243.9, ± 30, 232.7 ± 60, for IOMM- 
Lee, CH-157 MN, and cell lines from patients 3 and 5, respectively). Of the two primary 
cell lines from simple karyotypes, only one (patient 6) was processed for analysis. This
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cell line showed no cells positive for MIB-1 immunoreactivity. Interestingly, we observed 
that MIB-1 counts from operative specimens did not predict the ability to incite flank 
tumor growth. For example, patient 4 had the lowest MIB-1 mean but consistently 
incited flank tumors, whereas patient 5 had the highest MIB-1 ratio but incited 
nongrowing tumors (Figure 6).
TEM
TEM was used to identify ultrastructural features consistent with the diagnosis of 
meningiomas, specifically desmosomes. Desmosomes are intercellular junctions that 
anchor vimentin filaments to the cellular membrane and are characteristic of 
meningiomas. The key features of desmosomes are opposing disc-shaped plaques 
located on the cytoplasmic membrane, with inserting cytoplasmic tonofilament bundles, 
and an amorphous material present within the intercellular space (Figure 7). Four cell 
lines, three flank tumors, and one operative sample were processed for TEM. 
Ultrastructural features of the lOMM-Lee cell line include interdigitating cells with 
prominent nucleoli and intermediate filaments. Microvilli were noted on the cellular 
surface. Tight junctions (i.e., no intervening intercellular space) and junctions suggestive 
of desmosomes (i.e., intercellular gap with shaggy appearance to lipid bilayer) were 
visualized. These features still fit its initial description in 1990 [18]. Ultrastructurally, 
primary meningiomas grown in cell culture (from patients 4, 8, and 11) exhibited 
interdigitating cell processes without intercellular junctions. Flank tumors induced by the 
lOMM-Lee, CH-157 MN, and patient 5 cell lines were processed for TEM. The IOMM- 
Lee and CH-157 MN mouse flank tumors exhibited junctional complexes similar in
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a p p e a r a n c e  to  d e s m o s o m e s  b u t  lack in g  c le a r  c y to p la s m ic  to n o f i la m e n t in s e r t io n  (F ig u re  
7 ). T h e  m o u s e  f la n k  tu m o r  in d u c e d  fro m  th e  p a t ie n t  5  ce ll line e x h ib ite d  c le a r  
d e s m o s o m e s  (F ig u re  7).
D IS C U S S IO N
T h is  m a n u s c r ip t  a d d r e s s e s  tw o  lo n g -h e ld  c r it ic is m s  of th e  m o u s e  m e n in g o m a  
f la n k  m o d e l:  1. W h y  a r e  tu m o r  in d u c tio n  r a te s  s o  p o o r  in a n im a ls  in je c te d  w ith  ce ll l in e s  
d e r iv e d  fro m  o p e r a t iv e  s p e c im e n s ?  2 . A re  m o u s e  f la n k  tu m o rs  m e n in g io m a s ?  T h e  
a d v a n ta g e s  to  th e  m o u s e  x e n o g r a f t  m e n in g io m a  fla n k  m o d e l a r e  th e  e a s e  w ith  w h ich  
tu m o rs  c a n  b e  c o n tin u a lly  a s s e s s e d  d u rin g  t r e a tm e n ts  a n d  th e  re la tiv e ly  low  c o s t  of 
u s in g  m ic e  a s  a n  a n im a l m o d e l. H isto rica lly , th e  m e n in g io m a  m o u s e  f la n k  m o d e l w a s  
lim ited  b y  low  tu m o r  in d u c tio n  r a te s  until M atrig e l a u g m e n ta t io n  w a s  firs t d e s c r ib e d  in 
r e p o r ts  fro m  o u r  la b o ra to ry  in 1 9 9 8  [13 , 15]. Initially, M atrig e l a u g m e n ta t io n  w a s  n o te d  
to  in d u c e  tu m o rs  in 1 0 0 %  of m o u s e  f la n k s , b u t th is  initial r e p o r t  w a s  o p tim is tic  a n d  o u r  
e x p e r ie n c e  o v e r  th e  la s t  8  y e a r s  p l a c e s  tu m o r  in d u c tio n  c lo s e r  to  6 0 %  (R .L . J e n s e n ,  
p e r s o n a l  o b s e r v a t io n )  [13]. F u r th e rm o re ,  o th e r  in v e s t ig a to r s  h a v e  h a d  little s u c c e s s  in 
d u p lic a tin g  o u r  m o d e l (R .L  J e n s e n  p e r s o n a l  c o n v e r s a t io n s ) .  In th is  a n a ly s is ,  w e  
id en tif ied  th a t  m e n in g io m a s  g ro w n  in c u l tu re  c o n ta in in g  m u ltip le  c h r o m o s o m a l  
a b n o rm a li t ie s  c o n s is te n t ly  in d u c e d  f la n k  tu m o rs ,  w h e r e a s  n o rm a l c u l tu r e s  o r  t h o s e  w ith  
a  s in g le  c h r o m o s o m a l  a b n o rm a lity  d id  n o t. F ina lly , f la n k  tu m o rs  d e r iv e d  fro m  b o th  
im m o rta l ce ll l in e s  a n d  o p e r a t iv e  s p e c im e n s  ex h ib it h is to lo g ic , im m u n o h is to c h e m ic a l  
a n d  u l tra s tru c tu ra l  f e a tu r e s  c o n s i s t e n t  w ith  m e n in g io m a s .
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A  C o m p l e x  K a r y o ty p e  A p p e a r s  to  P r e d ic t  t h e  S u c c e s s f u l  G r o w th  o f  M e n i n g io m a s  in  
M o u s e  F la n k s
In th is  s tu d y , th e  c h r o m o s o m a l  a b n o rm a li t ie s  e x h ib i te d  a r e  c o n s i s te n t  w ith  
p re v io u s ly  r e p o r te d  m e n in g o m a  c h r o m o s o m a l  a b n o rm a li t ie s  [29]. C y to g e n e t ic  a n d  
m o le c u la r  s tu d ie s  h a v e  id en tif ied  lo s s  o f h e te ro z y g o s i ty  of c h r o m o s o m e  2 2  in ro u g h ly  
6 0 %  of all m e n in g io m a s ,  w ith  th e  N F 2  tu m o r  s u p p r e s s o r  g e n e ,  lo c a te d  o n  c h r o m o s o m e  
2 2 q 1 2 .1 , a n d  its p ro te in  p ro d u c t  (i.e ., s c h w a n n o m in  o r  M erlin) n o te d  to  b e  d y s fu n c tio n a l  
o r  lo s t in a p p ro x im a te ly  o n e  th ird  o f m e n in g o m a  c a s e s  [4, 9 , 19 , 2 0 , 2 9 , 3 3 , 4 2 , 43 ]. 
M an y  o th e r  c y to g e n e t ic  a l te r a t io n s  h a v e  b e e n  id en tif ied  a n d  a s s o c ia te d  w ith  a ty p ic a l o r  
a n a p la s t ic  h is to lo g y , in c lu d in g  th e  p r e s e n c e  o f d ic e n tr ic  o r  ring  c h r o m o s o m e s  a n d  
lo s s e s  of c h r o m o s o m e  a r m s  1 p, 6 q , 7 , 9 p , 10 , 1 4 q , 1 8 q , 19 , o r  2 0 , a s  w ell a s  
g a in s /a m p lif ic a t io n s  of 1 q , 9 q , 1 2 q , 1 5 q , 1 7 q , o r  2 0 q  [3, 5 , 7 , 8 , 16 , 17 , 19 , 2 7 , 2 8 , 3 2 ,
3 4 , 3 9 , 4 1 ]. T h e  im m o rta l ce ll l in e s  lO M M -L ee  a n d  C H -1 5 7  MN s h o w e d  c h ro m o s o m a l  
a b n o rm a li t ie s  c o n s i s t e n t  w ith  ce ll l in e s  p a s s a g e d  m u ltip le  t im e s .  M e n in g io m a s  from  
o p e r a t iv e  s a m p le s  fell in to  tw o  g r o u p s :  t h o s e  w ith  c o m p le x  a n d  t h o s e  w ith  s im p le  
k a ry o ty p e s .  T h e  th r e e  m e n in g io m a s  w ith  a  c o m p le x  k a ry o ty p e  (p a t ie n ts  3 , 4 , a n d  8) h a d  
s im ila r  a b n o rm a li t ie s ,  d e s p i t e  b e in g  fro m  th r e e  d if fe re n t m e n in g io m a  s u b ty p e s  
(m e n in g o th e lia l ,  t ra n s i t io n a l ,  a n d  p s a m m o m a to u s ) .  All th r e e  e x h ib ite d  a d d i t io n s  to  
c h r o m o s o m e s  4 , 6 , 9 , a n d  12  a n d  d e le t io n s  of c h r o m o s o m e  5 . M e n in g io m a s  w ith  a  
s im p le  k a ry o ty p e  e x h ib ite d  e i th e r  a  n o rm a l c h r o m o s o m a l  n u m b e r  (p a t ie n ts  5  a n d  7) o r  
m o n o s o m y  2 2  (p a tie n t  6 ). In te re s tin g ly , ce ll l in e s  w ith  th e  c o m p le x  k a ry o ty p e  g re w  
q u ick ly  in c u ltu re  a n d  w e re  a b le  to  in d u c e  m o u s e  f la n k  tu m o rs .
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C e ll c u l tu r e s  d e r iv e d  fro m  c o m p le x  k a ry o ty p e s  e x h ib ite d  f a s te r  g ro w th  r a te s  in  
v itro  a n d  c o n s is te n t ly  in d u c e d  fa s t-g ro w in g  m o u s e  f la n k  tu m o rs .  It is  u n c le a r  w h e th e r  
tu m o r  in d u c tio n  w a s  s im p ly  a  fu n c tio n  of th e  initial ce ll b u rd e n  in je c te d  s u b c u ta n e o u s ly  
in to  th e  f la n k s  o f n u d e  m ic e , s in c e  m e n in g io m a s  w ith  m u ltip le  c h r o m o s o m a l  
a b n o rm a li t ie s  g re w  q u ick ly  in c u ltu re ;  a  m u c h  g r e a t e r  c e llu la r  h a r v e s t  w a s  o b ta in a b le  by  
th e  fifth p a s s a g e ,  th e  a rb itra ry  cu t-o ff th a t  w e  s e t  fo r s u b c u t a n e o u s  in jec tio n . It is th e  
a u th o r s ’ b e lie f  th a t  m e n in g io m a s  w ith  m u ltip le  c h r o m o s o m a l  a b n o rm a li t ie s  a c t  m o re  
a g g r e s s iv e ly  b e c a u s e  of u n k n o w n  g e n e  d y s re g u la t io n  th a t  is n o t p r e s e n t  in 
m e n in g io m a s  w ith  s im p le  k a ry o ty p e s .
In te re s tin g ly , w e  o b s e r v e d  th a t  MIB-1 c o u n ts  fro m  o p e r a t iv e  s p e c im e n s  d id  n o t 
p re d ic t  th e  ab ility  to  in c ite  f la n k  tu m o r  g ro w th  (e .g .,  p a t ie n t  4  h a d  th e  lo w e s t  MIB-1 m e a n  
b u t c o n s is te n t ly  in c ite d  f la n k  tu m o rs ,  w h e r e a s  p a t ie n t  5  h a d  th e  h ig h e s t  MIB-1 ra tio  b u t 
o n ly  in c ite d  n o n -g ro w in g  f la n k  tu m o rs ) .  In d u c e d  m o u s e  tu m o rs  s h o w e d  s ig n if ic a n t MIB-1 
c o u n ts  w ith  > 3 0 %  of c e lls  s t a in e d  p o s itiv e , in d ic a tin g  h ig h  p ro life ra tiv e  r a te s .  O th e r s  
h a v e  r e p o r te d  MIB-1 in d e x  o f in tra c ra n ia l  lO M M -L ee  tu m o r s  to  b e  3 0 %  [40].
T h e  M e n in g io m a  M o u s e  X e n o g r a f t  F la n k  M o d e l  R e c a p i t u l a t e s  t h e  H is to lo g ic ,  
I m m u n o h i s to c h e m ic a l ,  a n d  U ltr a s tr u c tu r a l  F e a t u r e s  o f  M e n in g io m a s
All m e n in g io m a s  g ro w n  in m o u s e  f la n k s  s h o w e d  h is to lo g ic , 
im m u n o h is to c h e m ic a l ,  a n d  u l tra s tru c tu ra l  f e a tu r e s  c o n s i s te n t  w ith  m e n in g io m a s .  
P re v io u s  w o rk  h a s  c h a r a c te r i z e d  m e n in g io m a s  g ro w n  in  v itro  o n  a  m ic ro s c o p ic , 
im m u n o h is to c h e m ic a l ,  a n d  u l tra s tru c tu ra l  lev e l [12 , 14 , 3 1 ]. T h e s e  s tu d ie s  c o n c lu d e  th a t  
ce ll c u l tu r e s  d e r iv e d  fro m  m e n in g io m a  o p e r a t iv e  s a m p le s  a p p e a r  to  b e  of
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l e p to m e n in g e a l  o rig in . T h is  c o n c lu s io n  is b a s e d  o n  th e ir  p o ly g o n a l s h a p e ,  n e g a tiv e  
G F A P  s ta in in g , a n d  p o s it iv e  v im e n tin  a n d  EM A s ta in in g , a s  w ell a s  th e  e x h ib itio n  of 
d e s m o s o m e s  b y  e le c tro n  m ic ro s c o p y  [12 , 31 ]. L o w - p a s s a g e  c e lls  (n o  g r e a t e r  th a n  
p a s s a g e  5) w e re  u s e d  fo r t h e s e  e x p e r im e n ts ,  m a k in g  f ib ro b la s t  o v e rg ro w th  l e s s  likely. 
F ina lly , ce ll l in e s  u s e d  fo r in  v itro  w o rk  w e re  t r a n s p la n te d  in to  th e  f la n k s  of n u d e  m ic e  fo r 
in  v iv o  e x p e r im e n ts ,  a n d  th e  x e n o g r a f t  tu m o rs  th a t  d e v e lo p e d  r e s e m b le d  m e n in g io m a s  
h is to lo g ica lly , im m u n o h is to c h e m ic a lly ,  a n d  u ltra s tru c tu ra lly .
H is to lo g ica lly , m e n in g io m a s  g ro w n  in th e  m o u s e  f la n k  s h a r e d  a  h is to lo g ic  
f e a tu r e s  s im ila r  to  th a t  of th e  o rig in a l o p e r a t iv e  s p e c im e n  (e .g .,  im m o rta l ce ll l in e s  
e x h ib ite d  c y to a r c h i te c tu r e  of W H O  g r a d e  III m e n in g o m a  w ith  n u c le a r  p o ly m o rp h is m  a n d  
n u m e r o u s  m ito s is  a n d  f la n k  tu m o r s  fro m  o p e r a t iv e  s p e c im e n s  s h o w e d  lo b u la r  c e llu la r  
p a t t e r n s  s im ila r  to  th e ir  o rig in a l o p e r a t iv e  s p e c im e n s )  (F ig u re  5 ).
Im m u n o h is to c h e m ic a lly ,  th e  h a llm a rk  of m e n in g io m a s  is v im e n tin  p o s it iv e  s ta in in g  a n d  
n e g a t iv e  G F A P  s ta in in g , w ith  ro u g h ly  8 0 %  s ta in in g  fo r EM A . M o u s e  f la n k  tu m o rs  g ro w n  
fro m  m e n in g io m a  ce ll c u l tu re  s h o w e d  1 0 0 %  v im e n tin  im m u n o re a c tiv ity . In th is  a n a ly s is  
all f la n k  tu m o r s  e x h ib ite d  s im ila r  im m u n o h is to c h e m ic a l  s ta in in g s  a s  th e  o rig in a l 
o p e r a t iv e  s p e c im e n ,  w ith  th e  e x c e p t io n  of p a t ie n t  6 , w h ic h  lo s t EM A  re a c tiv ity  in th e  
f la n k  tu m o r . F ina lly , u l tra s tru c tu ra lly  m e n in g io m a s  g ro w n  in m o u s e  f la n k s  e x h ib ite d  
d e s m o s o m e s ,  a s  w ell a s  ju n c tio n a l c o m p le x e s  c o n s i s t e n t  w ith  m e n in g io m a s .
U ltr a s tr u c tu r a l  F e a t u r e s  o f  M e n in g io m a s
D e s m o s o m e s  a r e  in te rc e llu la r  ju n c t io n s  c h a r a c te r i s t ic  of m e n in g io m a s  a n d  
a r a c h n o id a l  t i s s u e  [1]. T h r e e  m o le c u la r  f e a tu r e s  a r e  ty p ic a l o f m e n in g io m a s :  v im e n tin ,
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EM A, a n d  d e s m o s o m e s  [1]. D e s m o s o m e s  a r e  u n iq u e  to  m e n in g io m a s  a n d  a r e  n o t 
e x h ib ite d  in o th e r  p r im a ry  in tra c ra n ia l  tu m o r s  [1]. A ra c h n o id a l  a n d  m e n in g io m a  
d e s m o s o m e s  a n c h o r  v im e n tin  f i la m e n ts  to  th e  c y to p la s m ic  m e m b ra n e .  T y p ica l 
u l tra s tru c tu ra l  f e a tu r e s  of m e n in g io m a s  in c lu d e  fla t a n d  o f te n  in te rd ig ita tin g  cell 
p r o c e s s e s ,  d e s m o s o m a l  s t r u c tu r e s ,  a n d  lo o s e ly  a r r a n g e d  v im e n tin  f i la m e n ts ,  th e  
a m o u n t  of w h ich  s tro n g ly  v a r ie s  [1]. C ell p r o c e s s e s  a n d  la rg e r  a r e a s  of ce ll b o d ie s  
d e n s e ly  p a c k e d  w ith  in te rm e d ia te  f i la m e n ts  w e re  a d ja c e n t  to  c e lls  w ith  o n ly  r a re  
in te rm e d ia te  f i la m e n t n e tw o rk s  [1]. In a d d itio n  to  d e s m o s o m e s ,  tw o  o th e r  ty p e s  of 
in te rc e llu la r  ju n c t io n s  h a v e  b e e n  d e s c r ib e d  in m e n in g io m a s  [1]. O n e  is c h a r a c te r i z e d  by  
c y to p la s m ic  p la q u e  s t r u c tu r e s ,  s m a l le r  a n d  l e s s  d e n s e  th a n  t h o s e  o f d e s m o s o m e s ,  a n d  
w ith o u t in te rm e d ia te  f i la m e n t a s s o c ia t io n  o f te n  fo rm e d  b y  th e  a p p r o a c h  of th r e e  c e llu la r  
e x te n s io n s .  T h e s e  in te rc e llu la r  ju n c t io n s  w ith  d if fu s e  c y to p la s m ic  p la q u e s  a n d  n o  
a s s o c ia te d  in te rm e d ia te  f i la m e n ts  a r e  f r e q u e n tly  fo u n d  in m e n in g io m a s ,  a s  w ell a s  
in te rc e llu la r  s t r u c tu r e s  w ith  a  p e n t i la m in a r  a p p e a r a n c e  [1]. T h e  o th e r  in te rc e llu la r  
c o n ta c t  w a s  fo rm e d  b y  th e  d ire c t  a t t a c h m e n t  o f n e ig h b o rh o o d  p la s m a  m e m b r a n e s ,  
fo rm in g  a  p e n t i la m in a r  s t r u c tu r e  [1].
Dr. W e i-H w a  L e e  first d e s c r ib e d  h is  i n t r a o s s e o u s  m a lig n a n t  m e n in g io m a  ce ll line 
(lO M M -L ee) in 1 9 9 0  a n d  e le c tro n  m ic ro s c o p y  s h o w s  u l tra s tru c tu ra l  f e a tu r e s  th a t  still fit 
its initial d e s c r ip tio n  of p ro m in e n t  n u c leo li, in te rm e d ia te  f i la m e n ts ,  a n d  s p a r s e  m icrovilli 
o n  th e  c e llu la r  s u r f a c e  [18]. W h e n  th e  lO M M -L ee  ce ll line  w a s  g ro w n  in  v iv o  a n d  
e x a m in e d  w ith  e le c tro n  m ic ro s c o p y , w e  id en tif ied  in te rc e llu la r  ju n c tio n a l c o m p le x e s  
c o n s i s t e n t  w ith  m e n in g io m a s  (F ig u re  7 ). T h e  C H -1 5 7  MN cell line g ro w n  in m o u s e
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f la n k s  a ls o  e x h ib ite d  s im ila r  ju n c tio n a l c o m p le x e s .  O n e  o p e r a t iv e  s p e c im e n  g ro w n  in  
v iv o  (p a tie n t  5 ) e x h ib i te d  d e s m o s o m e s .
R e c o m m e n d a t i o n s  fo r  I n d u c in g  M e n in g io m a  M o u s e  F la n k  T u m o r s
In d u c tio n  o f f la n k  tu m o rs  fro m  th e  im m o rta l ce ll l in e s  lO M M -L ee  a n d  C H -1 5 7  MN 
c a n  b e  s u c c e s s fu l ly  a c c o m p l is h e d  b y  in jec tin g  1 x 1 0 6 c e lls  s u s p e n d e d  in 0 .5  m L  of 
m e d ia  s u b c u ta n e o u s ly  in to  th e  f la n k s  o f n u d e  m ic e . O n e  T -1 7 5  f la s k  c o n ta in s  e n o u g h  
c e lls  to  in jec t a p p ro x im a te ly  3 0  m o u s e  f la n k s . In o u r  e x p e r ie n c e ,  th e r a p ie s  s h o u ld  b e  
in s titu te d  5 - 1 0  d a y s  a f te r  in jec tio n , b e c a u s e  t h e s e  tu m o rs  a p p e a r  to  “ta k e  off” a r o u n d  
tw o  w e e k s .  W a itin g  lo n g e r  to  in s titu te  th e r a p i e s  m a k e s  it d ifficult to  s e p a r a t e  g ro w th  
c u r v e s .
In d u c tio n  o f f la n k  tu m o rs  u s in g  p r im a ry  m e n in g o m a  ce ll l in e s  s h o u ld  b e  
u n d e r ta k e n  w ith  ce ll l in e s  th a t  a r e  id en tif ied  e i th e r  to  c o n ta in  m u ltip le  c h r o m o s o m a l  
a b n o rm a li t ie s  o r  to  g ro w  q u ick ly  in ce ll c u l tu re  w ith  d o u b lin g  t im e s  of l e s s  th a n  3  d a y s  
(7 2  h o u rs ) .  T h e  n u m b e r  o f c e lls  in je c te d  p e r  f la n k  s h o u ld  r a n g e  fro m  5 x 1 0 6 to  1 x 1 0 7 a n d  
b e  s u s p e n d e d  in 0 .5  m L  of M atrig e l. A lth o u g h  h ig h e r  ce ll n u m b e r s  w e re  in je c te d  in 
t h e s e  e x p e r im e n ts ,  t h e s e  tu m o r s  g re w  to o  q u ick ly  a n d  lo w erin g  th e  initial ce ll b u rd e n  
w o u ld  a id  in d e c r e a s in g  th e  ra p id  g ro w th . T r e a tm e n t  s h o u ld  b e  in s titu te d  b e tw e e n  10 
a n d  1 4  d a y s  a f te r  in jec tio n  to  a llo w  fo r M atrig e l re s o rp t io n .  S lo w -g ro w in g  m e n in g o m a  
ce ll l in e s  w ith  d o u b lin g  t im e s  g r e a t e r  th a n  3  d a y s  o r  s im p le  k a ry o ty p e s  a r e  n o t 
a m e n a b le  fo r in d u c e m e n t  o f s u b c u t a n e o u s  f la n k  tu m o rs .
C O N C L U S I O N S
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M e n in g io m a  ce ll c u l tu r e s  w ith  m u ltip le  c h r o m o s o m a l  a b n o rm a li t ie s  c o n s is te n t ly  
in d u c e  m o u s e  f la n k  tu m o rs .  T h e  m e n in g o m a  m o u s e  x e n o g r a f t  m o d e l r e c a p i tu la te s  th e  
h is to lo g ic , im m u n o h is to c h e m ic a l ,  a n d  u l tra s tru c tu ra l  f e a tu r e s  p r e s e n t  in m e n in g io m a s .
A C K N O W L E D G M E N T S
W e  th a n k  K ristin  K ra u s  fo r h e r  e x c e l le n t  ed ito r ia l a s s i s t a n c e ,  N a n c y  B. C h a n d le r  fo r h e r  
e le c tro n  m ic ro s c o p y  e x p e r t i s e ,  a n d  S h e ry l T rip p  fo r h e r  im m u n o h is to c h e m ic a l  s ta in in g  
e x p e r t i s e .  T h is  w o rk  w a s  s u p p o r te d  in p a r t  b y  a  g r a n t  fro m  th e  A m e r ic a n  A s s o c ia tio n  of 
N e u ro lo g ic a l S u r g e o n s  N e u ro s u rg e r y  R e s e a r c h  a n d  E d u c a tio n  F o u n d a tio n  to  B rian  
R a g e l.
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R E F E R E N C E S
1. A k a t K, M e n n e l HD , K re m e r  P , e t  a l. M o le c u la r  c h a r a c te r iz a t io n  o f d e s m o s o m e s  
in m e n in g io m a s  a n d  a r a c h n o id a l  t i s s u e .  A c ta  N e u ro p a th o l  (B erl) 2 0 0 3 ;1 0 6 :3 3 7 -  
3 4 7 .
2 . A l-R o d h a n  R F , L a w s  E R . T h e  H is to ry  of In tra c ra n ia l M e n in g io m a s . In: A l-M efty  
O , e d .  M e n in g io m a s . N e w  Y ork : R a v e n  P r e s s ,  L td.; 1 9 9 1 :1 -6 .
3 . Al S a a d i  A, L a tim e r F, M a d e rc ic  M, e t  a l. C y to g e n e t ic  s tu d ie s  of h u m a n  b ra in  
tu m o r s  a n d  th e ir  c lin ica l s ig n if ic a n c e . II. M e n in g io m a . C a n c e r  G e n e t  C y to g e n e t  
1 9 8 7 ;2 6 :1 2 7 -1 4 1 .
4 . B ig n e r  S H , M ark  J ,  B ig n e r  DD. C y to g e n e t ic s  of h u m a n  b ra in  tu m o rs .  C a n c e r  
G e n e t  C y to g e n e t  1 9 9 0 ;4 7 :1 4 1 -1 5 4 .
5 . B o s tro m  J ,  M e y e r  P u ttlitz  B, W o lte r  M, e t  a l. A lte ra t io n s  of th e  tu m o r  s u p p r e s s o r  
g e n e s  C D K N 2 A  (p 1 6 (IN K 4 a )) , p 1 4 (A R F ), C D K N 2 B  (p 1 5 (IN K 4 b )), a n d  C D K N 2 C  
(p 1 8 (IN K 4 c)) in a ty p ic a l  a n d  a n a p la s t ic  m e n in g io m a s .  A m  J  P a th o l 
2 0 0 1 ;1 5 9 :6 6 1 -6 6 9 .
6 . B u rg e r  P C , S c h e i th a u e r  B W , V o g e l F S , e d s .  S u rg ic a l  P a th o lo g y  of th e  N e rv o u s  
S y s te m  a n d  Its C o v e r in g s .  F o u rth  e d .  P h ila d e lp h ia :  C h u rch h ill L iv in g s to n e ; 2 0 0 2 .
7 . C a i DX, B a n e r je e  R, S c h e i th a u e r  B W , e t  a l. C h ro m o s o m e  1 p  a n d  1 4 q  F IS H  
a n a ly s i s  in c l in ic o p a th o lo g ic  s u b s e t s  of m e n in g io m a : d ia g n o s t ic  a n d  p ro g n o s t ic  
im p lic a tio n s . J  N e u ro p a th o l  E x p  N e u ro l 2 0 0 1 ;6 0 :6 2 8 -6 3 6 .
8 . C a i DX, J a m e s  C D , S c h e i th a u e r  B W , e t  a l. P S 6 K  am p lif ic a tio n  c h a r a c te r i z e s  a  
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9 . D u m a n s k i J P ,  R o u le a u  G A , N o rd e n s k jo ld  M, e t  a l. M o le c u la r  g e n e t ic  a n a ly s i s  of 
c h r o m o s o m e  2 2  in 81 c a s e s  o f m e n in g io m a . C a n c e r  R e s  1 9 9 0 ;5 0 :5 8 6 3 -5 8 6 7 .
10 . G o n z a le s  M F. C la s s if ic a t io n  of b ra in  tu m o rs .  In: K a y e  A H , L a w s  E R , e d s .  B ra in  
T u m o rs .  1 s t  e d .  E d in b u rg h : C h u rch ill L iv in g s to n e ; 1 9 9 5 :6 7 5 .
11 . G r e e n e  H S , A rn o ld  H. T h e  h o m o lo g o u s  a n d  h e te r o lo g o u s  t r a n s p la n ta t io n  o f b ra in  
a n d  b ra in  tu m o rs .  J  N e u ro s u rg  1 9 4 5 ;2 :3 1 5 -3 2 9 .
12 . J e n s e n  RL, L e e  Y S , G u ijra ti M, e t  a l. Inh ib ition  o f in v itro  m e n in g io m a  
p ro life ra tio n  a f te r  g ro w th  fa c to r  s t im u la tio n  b y  c a lc iu m  c h a n n e l  a n ta g o n is t s :  P a r t  
II—A d d itio n a l g ro w th  fa c to r s ,  g ro w th  fa c to r  r e c e p to r  im m u n o h is to c h e m is try ,  a n d  
in tra c e llu la r  c a lc iu m  m e a s u r e m e n t s .  N e u ro s u rg e r y  1 9 9 5 ;3 7 :9 3 7 -9 4 6 ;  d is c u s s io n  
9 4 6 -9 4 7 .
13 . J e n s e n  RL, L e p p la  D, R o k o s z  N, e t  a l. M atrig e l a u g m e n t s  x e n o g ra f t  
t r a n s p la n ta t io n  o f m e n in g io m a  c e lls  in to  a th y m ic  m ic e . N e u ro s u rg e r y  
1 9 9 8 ;4 2 :1 3 0 -1 3 5 ;  d is c u s s io n  1 3 5 -1 3 6 .
14 . J e n s e n  RL, O rig ita n o  T C , L e e  Y S , e t  a l. In v itro  g ro w th  inh ib ition  of g ro w th  fa c to r-  
s t im u la te d  m e n in g io m a  c e lls  b y  c a lc iu m  c h a n n e l  a n ta g o n is t s .  N e u ro s u rg e r y  
1 9 9 5 ;3 6 :3 6 5 -3 7 3 ;  d is c u s s io n  3 7 3 -3 7 4 .
15 . J e n s e n  RL, W u rs te r  R D . C a lc iu m  c h a n n e l  a n ta g o n i s t s  inh ib it g ro w th  of 
s u b c u t a n e o u s  x e n o g r a f t  m e n in g io m a s  in n u d e  m ic e . S u rg  N e u ro l 2 0 0 1  ;5 5 :2 7 5 -  
2 8 3 .
16 . K a ts u y a m a  J ,  P a p e n h a u s e n  P R , H e rz  F, e t  a l. C h r o m o s o m e  a b n o rm a li t ie s  in 
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17 . L a m s z u s  K, K luw e L, M a ts c h k e  J ,  e t  al. A llelic l o s s e s  a t  1 p, 9 q , 1 0 q , 1 4 q , a n d  
2 2 q  in th e  p ro g r e s s io n  of a g g r e s s iv e  m e n in g io m a s  a n d  u n d if fe re n tia te d  
m e n in g e a l  s a r c o m a s .  C a n c e r  G e n e t  C y to g e n e t  1 9 9 9 ;1 1 0 :1 0 3 -1 1 0 .
18 . L e e  W H . C h a ra c te r iz a t io n  of a  n ew ly  e s ta b l i s h e d  m a lig n a n t  m e n in g io m a  ce ll line 
o f th e  h u m a n  b ra in : lO M M -L ee. N e u ro s u rg e r y  1 9 9 0 ;2 7 :3 8 9 -3 9 5 ;  d i s c u s s io n  3 9 6 .
19 . L e k a n n e  D e p re z  R H , B ian ch i AB, G ro e n  NA, e t  a l. F r e q u e n t  N F 2  g e n e  tr a n s c r ip t  
m u ta t io n s  in s p o r a d ic  m e n in g io m a s  a n d  v e s t ib u la r  s c h w a n n o m a s .  A m  J  H um  
G e n e t  1 9 9 4 ;5 4 :1 0 2 2 -1 0 2 9 .
2 0 . L e o n  S P ,  Z h u  J ,  B lack  PM . G e n e t ic  a b e r r a t io n s  in h u m a n  b ra in  tu m o rs .  
N e u ro s u rg e r y  1 9 9 4 ;3 4 :7 0 8 -7 2 2 .
2 1 . L o u is  DN, S c h e i th a u e r  B W , B u d k a  H, e t  a l., e d s .  M e n in g io m a s . L yon : IA RC 
P r e s s ;  2 0 0 0 . K le ih u e s  P , C a v e n e e  W K , e d s .  W o rld  H e a lth  O rg a n iz a t io n  
C la s s if ic a t io n  of T u m o u rs :  P a th o lo g y  a n d  G e n e t ic s :  T u m o u rs  of th e  N e rv o u s  
S y s te m .
2 2 . M a h m o o d  A, C a c c a m o  DV, T o m e c e k  F J , e t  a l. A ty p ica l a n d  m a lig n a n t  
m e n in g io m a s :  a  c l in ic o p a th o lo g ic a l re v ie w . N e u ro s u rg e r y  1 9 9 3 ;3 3 :9 5 5 -9 6 3 .
2 3 . M a r tu z a  RL, M alick  A, M a rk e rt JM , e t  a l. E x p e r im e n ta l  th e r a p y  of h u m a n  g lio m a  
b y  m e a n s  of a  g e n e tic a l ly  e n g in e e r e d  v iru s  m u ta n t .  S c ie n c e  1991 ;2 5 2 :8 5 4 -8 5 6 .
2 4 . M c C u tc h e o n  IE, F rie n d  KE, G e r d e s  TM , e t  a l. In tra c ra n ia l  in jec tio n  o f h u m a n  
m e n in g io m a  c e lls  in a th y m ic  m ic e : a n  o r th o to p ic  m o d e l fo r m e n in g io m a  g ro w th . J  
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2 5 . M e d h k o u r  A, V a n  R o e y  M, S o b e l  RA, e t  a l. Im p la n ta tio n  of h u m a n  m e n in g io m a s  
in to  th e  s u b r e n a l  c a p s u le  of th e  n u d e  m o u s e .  A m o d e l fo r s tu d ie s  of tu m o r  
g ro w th . J  N e u ro s u rg  1 9 8 9 ;7 1 :5 4 5 -5 5 0 .
2 6 . O ls o n  J J ,  B e c k  DW , S c h le c h te  JA , e t  a l. E ffec t of th e  a n t ip r o g e s te r o n e  R U -3 8 4 8 6  
o n  m e n in g io m a  im p la n te d  in to  n u d e  m ic e . J  N e u ro s u rg  1 9 8 7 ;6 6 :5 8 4 -5 8 7 .
2 7 . O z a k i S , N ish izak i T , Ito H, e t  a l. C o m p a ra t iv e  g e n o m ic  h y b rid iz a tio n  a n a ly s i s  of 
g e n e t ic  a l te r a t io n s  a s s o c ia te d  w ith  m a lig n a n t  p ro g r e s s io n  of m e n in g io m a . J  
N e u ro o n c o l  1 9 9 9 ;4 1 :1 6 7 -1 7 4 .
2 8 . P r e m p r e e  T , A m o rn m a rn  R, F a i l la c e  W J , e t  a l. 1 ;1 9  t r a n s lo c a t io n  in h u m a n  
m e n in g io m a . C a n c e r  1 9 9 3 ;7 1 :2 3 0 6 -2 3 1 1.
2 9 . R a g e l  BT, J e n s e n  RL. M o le c u la r  g e n e t i c s  of m e n in g io m a s .  N e u ro s u rg  F o c u s  
2 0 0 5 ;1 9 :E 9 .
3 0 . R a n a  M W , P in k e r to n  H, T h o rn to n  H, e t  a l. H e te ro t r a n s p la n ta t io n  o f h u m a n  
g l io b la s to m a  m u ltifo rm e  a n d  m e n in g io m a  to  n u d e  m ic e . P ro c  S o c  E x p  Biol M ed  
1 9 7 7 ;1 5 5 :8 5 -8 8 .
3 1 . R u tk a  JT , G ib lin  J ,  D o u g h e r ty  DV, e t  a l. A n u ltra s tru c tu ra l  a n d  
im m u n o c y to c h e m ic a l  a n a ly s i s  of le p to m e n in g e a l  a n d  m e n in g io m a  c u l tu re s .  J  
N e u ro p a th o l  E x p  N e u ro l 1 9 8 6 ;4 5 :2 8 5 -3 0 3 .
3 2 . S c h n e id e r  B F , S h a s h i  V, v o n  K ap  h e r r  C , e t  a l. L o s s  of c h r o m o s o m e s  2 2  a n d  14  
in th e  m a lig n a n t  p ro g r e s s io n  of m e n in g io m a s .  A c o m p a r a t iv e  s tu d y  of 
f lu o r e s c e n c e  in s itu  h y b rid iz a tio n  (F IS H ) a n d  s t a n d a r d  c y to g e n e t ic  a n a ly s is .  
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3 3 . S e iz in g e r  B R , d e  la  M o n te  S , A tk in s  L, e t  a l. M o le c u la r  g e n e t ic  a p p r o a c h  to  
h u m a n  m e n in g io m a : lo s s  of g e n e s  o n  c h r o m o s o m e  2 2 . P ro c  N atl A c a d  S c i U S  A 
1 9 8 7 ;8 4 :5 4 1 9 -5 4 2 3 .
3 4 . S im o n  M, v o n  D eim lin g  A, L a rs o n  J J ,  e t  a l. A llelic l o s s e s  o n  c h r o m o s o m e s  14,
10 , a n d  1 in a ty p ic a l  a n d  m a lig n a n t  m e n in g io m a s :  a  g e n e t ic  m o d e l of 
m e n in g io m a  p r o g r e s s io n .  C a n c e r  R e s  1 9 9 5 ;5 5 :4 6 9 6 -4 7 0 1 .
3 5 . S im p s o n  D. T h e  r e c u r r e n c e  of in tra c ra n ia l  m e n in g io m a s  a f te r  s u rg ic a l  t r e a tm e n t .
J  N e u ro c h e m  1 9 5 7 ;2 0 :2 2 -3 9 .
3 6 . T s a i  J C ,  G o ld m a n  C K , G ille s p ie  G Y . V a s c u la r  e n d o th e l ia l  g ro w th  fa c to r  in h u m a n  
g lio m a  ce ll l in e s : in d u c e d  s e c r e t io n  b y  E G F , P D G F -B B , a n d  b F G F . J  N e u ro s u rg  
1 9 9 5 ;8 2 :8 6 4 -8 7 3 .
3 7 . T s a i  J C ,  H s ia o  YY, T e n g  LJ, e t  a l. R e g u la t io n  of v a s c u la r  e n d o th e l ia l  g ro w th  
fa c to r  s e c r e t io n  in h u m a n  m e n in g io m a  c e lls .  J  F o rm o s  M ed  A s s o c  1 9 9 9 ;9 8 :1 11- 
1 1 7 .
3 8 . U e y a m a  Y, M o rita  K, O c h ia i C , e t  a l. X e n o tr a n s p la n ta t io n  of a  h u m a n  
m e n in g io m a  a n d  its lu n g  m e t a s t a s i s  in n u d e  m ic e . Br J  C a n c e r  1 9 7 8 ;3 7 :6 4 4 -6 4 7 .
3 9 . V a g n e r  C a p o d a n o  AM , G riso li F, G a m b a re ll i  D, e t  a l. C o rre la tio n  b e tw e e n  
c y to g e n e t ic  a n d  h is to p a th o lo g ic a l  f in d in g s  in 7 5  h u m a n  m e n in g io m a s .  
N e u ro s u rg e r y  1 9 9 3 ;3 2 :8 9 2 -9 0 0 ;  d i s c u s s io n  9 0 0 .
4 0 . v a n  F u rth  W R , L au g h lin  S , T a y lo r  M D, e t  a l. Im a g in g  o f m u rin e  b ra in  tu m o rs  
u s in g  a  1 .5  T e s la  c lin ica l MRI s y s te m .  C a n  J  N e u ro l S c i 2 0 0 3 ;3 0 :3 2 6 -3 3 2 .
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4 1 . W e b e r  R G , B o s tro m  J ,  W o lte r  M, e t  a l. A n a ly s is  of g e n o m ic  a l te r a t io n s  in b e n ig n , 
a ty p ic a l, a n d  a n a p la s t ic  m e n in g io m a s :  to w a rd  a  g e n e t ic  m o d e l of m e n in g io m a
£  p r o g r e s s io n .  P ro c  N atl A c a d  S c i U S  A 1 9 9 7 ;9 4 :1 4 7 1 9 -1 4 7 2 4 .
C
^  4 2 . W e lle n re u th e r  R , K ra u s  JA , L e n a r tz  D, e t  a l. A n a ly s is  of th e  n e u ro f ib ro m a to s is  2
nr
oK
g e n e  r e v e a ls  m o le c u la r  v a r ia n ts  o f m e n in g io m a . A m  J  P a th o l 1 9 9 5 ;1 4 6 :8 2 7 -8 3 2 . 
4 3 . W olff RK, F ra z e r  KA, J a c k le r  RK, e t  al. A n a ly s is  of c h r o m o s o m e  2 2  d e le t io n s  in
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II. 4 I f /t t  t t i  ti i» i
F ig u re  1: R e p r e s e n ta t iv e  G ie m s a - b a n d  a n a ly s i s  o f s im p le  (A) a n d  c o m p le x  (B) 
k a ry o ty p e s .  A. P a t ie n t  6  s h o w e d  a  s im p le  k a ry o ty p e  w ith  m o n o s o m y  2 2  (a rro w ). B. 
P a t ie n t  4  e x h ib ite d  a  c o m p le x  k a ry o ty p e  w ith  m u ltip le  c h r o m o s o m a l  a b n o rm a li t ie s  
p rim arily  invo lv ing  c h r o m o s o m e s  1, 4 , 5 , 6 , 9  a n d  1 2  (a rro w s ) .
■A. IOMM-Lee 
■B. C H -157 MN 
■C. Patient # 3  
■D. Patient # 4  
■E. Patient # 5  
• F. Patient # 7
T im e (h o u r s)
F ig u re  2 : L o g a r ith m ic  g r a p h  (L o g 1 0 ) c o m p a r in g  th e  in  v itro  g ro w th  r a te s  of im m o rta l ce ll 
l in e s  (A -B ) a n d  b e n ig n  m e n in g io m a s  c u lt iv a te d  from  o p e r a t iv e  s a m p le s  ( C - F ,  T a b le  1, 
P a t ie n ts  3 , 4 , 5 , a n d  7 ). T h e  lO M M -L ee  (A) a n d  C H -1 5 7  MN (B) m a lig n a n t  ce ll l in e s  
s h o w e d  d o u b lin g  t im e s  of - 2 0  a n d  - 2 3  h o u rs ,  r e s p e c t iv e ly .  C u l tu r e s  o b ta in e d  from  
o p e r a t iv e  s p e c im e n s  fell in to  f a s t-  a n d  s lo w -g ro w in g  g r o u p s  (C -F ) .  F a s te r -g ro w in g  cell 



















r e s p e c t iv e ly .  C ell l in e s  fro m  p a t ie n ts  5  a n d  7  ( E - F )  s h o w e d  s lo w e r  g ro w th  w ith  d o u b lin g  
t im e s  o f - 1 2 0 .  N o te : O p e ra t iv e  s p e c im e n s  e x h ib ite d  c o n ta c t  inh ib ition  w ith  s lo w in g  of 
th e ir  g ro w th  r a te s  a s  th e y  r e a c h e d  c o n f lu e n c e ,  u n lik e  th e  im m o rta l ce ll l in e s . E rro r b a r s  
r e p r e s e n t  s t a n d a r d  d e v ia t io n  (± S .D ).
U n i v e r s i t y  o f  U t a h  I n s t i t u t i o n a l  R e p o s i t o r y
A u th o r  M a n u sc rip t
R a g e l  e t  a l. 3 3
F ig u re  3 : F lo w  c y to m e try  ce ll c y c le  c h a r a c te r i s t ic s  of lo g a rith m ic  g ro w in g  m e n in g o m a  
im m o rta l ce ll l in e s  a n d  ce ll l in e s  fro m  o p e r a t iv e  s p e c im e n s  (T a b le  1, P a t ie n ts  4 , 5 , 8 , 9 , 
a n d  11 ). T h e  im m o rta l ce ll l in e s  I O M M -L ee  (A) a n d  C H -1 5 7  MN (B) s h o w e d  a  g r e a t e r  
p e r c e n ta g e  o f c e lls  in s y n th e s i s  (S ) p h a s e  w h e n  c o m p a r e d  w ith  th e  five  b e n ig n  ce ll lin e s  
a n a ly z e d  (C -G ) .  B e n ig n  m e n in g io m a s  e x h ib ite d  v a riab ility  in th e  p e r c e n t  of c e lls  in g a p  



















U n i v e r s i t y  o f  U t a h  I n s t i t u t i o n a l  R e p o s i t o r y
A u th o r  M a n u sc rip t
R a g e l  e t  a l. 3 4
F lank  T um or G row th S urv ival P ro p o r tio n s
lOMM-Lee 
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F ig u re  4 : L ine g r a p h s  d e p ic t in g  th e  g ro w th  of m e n in g io m a  s u b c u t a n e o u s  f la n k  tu m o rs ,  
a s  w ell a s  c o r r e s p o n d in g  m o u s e  su rv iv a l p ro p o r tio n s . A. T h e  im m o rta l ce ll l in e s  in d u c e d  
f la n k  tu m o rs  in 9 5 %  (1 9 /2 0 )  a n d  1 0 0 %  (1 0 /1 0 )  o f a n im a ls  fo r th e  lO M M -L ee  a n d  C H - 
1 5 7  MN ce ll l in e s , r e s p e c tiv e ly .  F o u r  of 2 0  (2 0 % ) a n im a ls  d ie d  in th e  lO M M -L ee  g ro u p , 
w h e r e a s  n o  a n im a ls  d ie d  in th e  C H -1 5 7  MN g ro u p . A n im a ls  w e re  s a c r i f ic e d  a f te r  4 3  
d a y s  a t  v a ry in g  t im e s  b e c a u s e  of tu m o r  s iz e ,  p e r  a n im a l p ro to c o l. E rro r b a r s  r e p r e s e n t  
± S .D . . B. T w o  c o m p le x  k a ry o ty p e  ce ll l in e s  (P a t ie n ts  3  a n d  4 ) s h o w e d  1 0 0 %  (5 /5 ) 
tu m o r  in d u c tio n . O n e  (2 0 % ) of five  a n im a ls  w ith  s u b c u t a n e o u s  tu m o rs  in d u c e d  from  
p a t ie n t  4  d ie d . All a n im a ls  w e re  s a c r i f ic e d  a t  3 6  d a y s  b e c a u s e  of tu m o r  s iz e ,  p e r  a n im a l 
p ro to c o l. E rro r b a r s  r e p r e s e n t  ± S .D . C . T w o  s im p le  k a ry o ty p e  ce ll l in e s  in c ited  tu m o rs  
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F ig u re  5 : R e p r e s e n ta t iv e  h is to lo g y  a n d  im m u n o h is to c h e m ic a l  s ta in in g  s l id e s  of 
m e n in g io m a  o p e r a t iv e  s p e c im e n s  a n d  s u b c u t a n e o u s  m o u s e  f la n k  tu m o rs  (4 0 x  
o b je c t iv e , b a r  = 1 0 0  \xm ). A -B . M o u s e  f la n k  tu m o rs  in d u c e d  b y  th e  im m o rta l ce ll l in e s  
lO M M -L ee (A) a n d  C H  157 -M N  (B). C - F .  M e n in g o m a  o p e r a t iv e  s p e c im e n s  a n d  th e ir  
c o r r e s p o n d in g  s u b c u t a n e o u s  m o u s e  f la n k  tu m o r. R e p r e s e n ta t iv e  tu m o rs  in d u c e d  fro m  a  
c o m p le x  k a ry o ty p e  (C -D , P a t ie n t  4 ) a n d  a  s im p le  k a ry o ty p e  ( E - F ,  P a t ie n t  6) a r e  s h o w n . 
A -B . B o th  th e  lO M M -L ee (A) a n d  C H -1 5 7  MN (B) f la n k  tu m o rs  e x h ib ite d  f e a tu r e s  of 
W H O  III m e n in g io m a s  of n u c le a r  p o ly m o rp h is m , n u m e r o u s  m ito s is , a n d  h igh  
p ro life ra tiv e  r a t e s  (M IB -1). C H -1 5 7  MN tu m o r s  r e s e m b le d  th e  W H O  g r a d e  III rh a b d o id  
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S tro n g  v im e n tin  a n d  w e a k  EM A im m u n o re a c tiv ity  w a s  n o te d  in b o th . C . T h e  o p e r a t iv e  
s p e c im e n  fro m  p a t ie n t  4  s h o w e d  H&E c h a r a c te r i s t ic s  of a  t ra n s i t io n a l  m e n in g o m a  (e .g .,  
lo b u la r  p a t te r n  w ith  o c c a s io n a l  w h o rl- lik e  s t ru c tu re ) ,  w ith  s p a r s e  MIB-1 s ta in in g . D. T h e  
m o u s e  f la n k  tu m o r  in d u c e d  fro m  p a t ie n t  4  e x h ib ite d  H& E s im ila r it ie s  w ith  th e  o rig in a l 
o p e r a t iv e  s p e c im e n .  H o w e v e r , in c o m p a r is o n  w ith  th e  o rig in a l s p e c im e n ,  MIB-1 
im m u n o h is to c h e m is try  s h o w e d  a  m u c h  h ig h e r  p ro life ra tiv e  ra te .  S tro n g  v im e n tin  a n d  
w e a k  EM A im m u n o re a c tiv ity  w a s  n o te d  in b o th  th e  o p e r a t iv e  a n d  f la n k  tu m o r  
s p e c im e n s .  E. T h e  o p e r a t iv e  s p e c im e n  fro m  p a t ie n t  6  s h o w e d  H&E c h a r a c te r i s t ic s  of a  
f ib ro u s  m e n in g io m a  (e .g .,  p a ra lle l  s p in d le  c e lls  w ith  w id e  f a s c ic le s ) ,  w ith  a  fe w  c e lls  
s ta in in g  p o s it iv e  fo r M IB -1 . F. In te re s tin g ly , th e  m o u s e  tu m o r  fro m  p a t ie n t  6  e x h ib ite d  
w h o rls , c o n s i s t e n t  w ith  a  tr a n s i t io n a l  m e n in g o m a , u n lik e  th e  o rig in a l o p e r a t iv e  
s p e c im e n .  N o c e lls  s t a in e d  p o s it iv e  fo r M IB -1 . M o d e ra te  a n d  w e a k  v im e n tin  
im m u n o s ta in in g  w a s  n o te d  in th e  o p e r a t iv e  a n d  f la n k  tu m o r  s p e c im e n .  W e a k  a n d  n o  
EM A  im m u n o re a c tiv ity  w a s  o b s e r v e d  in th e  o p e r a t iv e  a n d  f la n k  s p e c im e n s ,  
re s p e c t iv e ly .
U n i v e r s i t y  o f  U t a h  I n s t i t u t i o n a l  R e p o s i t o r y
A u th o r  M a n u sc rip t
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U n i v e r s i t y  o f  U t a h  I n s t i t u t i o n a l  R e p o s i t o r y
A u th o r  M a n u sc rip t
R a g e l  e t  a l. 3 7
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F ig u re  6 : A -B . B a r  g r a p h s  d e p ic t in g  th e  m e a n  n u m b e r  o f c e lls  s ta in in g  p o s i t iv e  fo r MIB-
1 in 4 0 x  h ig h -p o w e re d  f ie ld s  (hpf) in th e  m e n in g io m a  o p e r a t iv e  s p e c im e n s  (A) a n d  
m o u s e  f la n k  tu m o rs  (B). E rro r b a r s  r e p r e s e n t  s t a n d a r d  d e v ia tio n  (± S .D ). A. T h e  o rig in a l 
o p e r a t iv e  s p e c im e n s  fo r th e  im m o rta l ce ll l in e s  w e re  u n a v a ila b le  fo r a n a ly s is .  T h e  tw o  
o p e r a t iv e  s p e c im e n s  th a t  in d u c e d  m o u s e  f la n k  tu m o rs  s h o w e d  MIB-1 c o u n ts  of 5 .7  ± 
4.1 a n d  1.1 ± 1 .1  fo r p a t ie n ts  3  a n d  4 , r e s p e c t iv e ly .  T h e  tw o  o p e r a t iv e  s p e c im e n s  th a t  
s h o w e d  tu m o r  r e g r e s s io n  s h o w e d  MIB-1 c o u n ts  of 1 .9  ±  1 .3  a n d  1 3 .6  ± 6 .8 , fo r p a t ie n ts  



















p e r  hp f (2 1 1 .0  ± 7 5 .7 , 1 9 0 .6  ± 2 3 .8 ,  2 4 3 .9  ± 3 0 , 2 3 2 .7  ± 6 0  fo r lO M M -L ee, C H -1 5 7  M N, 
a n d  p a t ie n ts  3  a n d  5 , r e s p e c t iv e ly ) .
U n i v e r s i t y  o f  U t a h  I n s t i t u t i o n a l  R e p o s i t o r y
A u th o r  M a n u sc rip t
R a g e l  e t  a l. 3 8
F ig u re  7 : T ra n s m is s io n  e le c tro n  m ic ro s c o p y  (T E M ) p ic tu re s  of a  m e n in g o m a  o p e r a t iv e  
s p e c im e n  (A) a n d  m e n in g io m a  m o u s e  f la n k  tu m o rs  (B -D ) . T h r e e  in te rc e llu la r  ju n c tio n  
ty p e s  h a v e  b e e n  d e s c r ib e d  p re v io u s ly  in m e n in g io m a s :  D e s m o s o m e s  (d), in te rc e llu la r  
ju n c t io n s  (ij), a n d  p e n t i la m in a r  s t r u c tu r e s  (d o u b le  a r ro w s ) .  A. P a t ie n t  6 , o rig in a l 
o p e r a t iv e  s p e c im e n ,  e x h ib itin g  th e  k e y  f e a tu r e s  of a  d e s m o s o m e :  o p p o s in g  d i s c - s h a p e d  
p la q u e s  lo c a te d  o n  th e  c y to p la s m ic  m e m b ra n e ,  w ith  in se r t in g  in te rm e d ia te  f i la m e n ts  (if), 
a n d  a n  a m o r p h o u s  m a te r ia l  p r e s e n t  w ith in  th e  in te rc e llu la r  s p a c e  (a rro w ). O rig in a l 



















m o u s e  f la n k  tu m o rs  e x h ib ite d  in te rc e llu la r  ju n c tio n a l (ij) c o m p le x e s ,  w h ic h  la c k  in se r tin g  
in te rm e d ia te  f i la m e n ts .  lO M M -L ee  o rig in a l m a g n if ic a tio n  2 5 ,4 2 2 x  a n d  5 2 ,0 2 0 x  ( in se t) .  
C H -1 5 7  MN o rig in a l m a g n if ic a tio n  8 ,2 8 6 x  a n d  3 3 ,7 8 2 x  ( in se t) .  D. P a t ie n t  5 , m o u s e  f la n k  
tu m o r , e x h ib itin g  all t h r e e  ty p e s  o f m e n in g io m a  ju n c tio n s .  O rig in a l m a g n if ic a tio n  4 8 ,6 0 0 x  
a n d  6 8 ,0 4 0 x  ( in se t) .
U n i v e r s i t y  o f  U t a h  I n s t i t u t i o n a l  R e p o s i t o r y
A u th o r  M a n u sc rip t



















U n i v e r s i t y  o f  U t a h  I n s t i t u t i o n a l  R e p o s i t o r y
A u th o r  M a n u sc rip t
R a g e l  e t  a l. 4 0
T a b le  1: C h a ra c te r i s t ic s  of th e  m e n in g io m a s  u s e d  in th is  c o m p a r is o n  s tu d y
P atien t
n o ./S e x /A a e
T um or G rade* / 
S u b tv o e
L ocation M odel
N um ber
C h r o m o so m a l A b n o rm a lit ie s
1. IOMM- 
Lee.
M / 6 1  (18)
WHO III In traosseous 4 8  (44 -  
49)
X, -Y, ±  add (2)(p11.2), add 
(5)(p13), add (6)(p13), i(7)(p10)x2, 
add(9M a21), a d d (1 2 )(a 2 1 ), -17. 
add(14)(a13), ad d(19), add(20), and  
+ 2-4  mar[p20].
2. C H -157  
MN.
F / 5 5  (36, 
37)
Unknown Unknown 7 3 - 8 2
<3n>
X. add (X)(d1 1.2), -X. add(1)(a21). 
ad d(1V o13). +2. +3. +5. -1. 
i(8)(q10)x2, +8, a d d (1 1 )(p 11.2), +11,  
+12. add(14)(p11.2), -15, i(15)(q10), - 
16, +16, -17, -J8, ±20, -22, +4-9m ar  
[cp10]
3. M / 7 1 WHO 1/
M eningothelial
Tentorial 4 7  (46 -  
48)
X. ad d M )to34 ). a d d (4 )fo 1 2 ). 
+ d el(5 )(q 31 ), a d d (6 )(q 2 7 ), 
+add(9)(D 21). a d d (12K a21) [cd201
4. M /  55 WHO 1/ 
Transitional
C onvexity 4 7  (47 -  
48)
X. ad d (1H o34), ad d(4K o12), 
+ d el(5 )(q 31 ), a d d (6 )(q 27 ), 
+ a d d (9 )(o 2 1 ), a d d (1 2 )(a 2 1 ),
add(12)(q23)[cp20]
5. F / 7 1 WHO 1/  
Transitional
S ph en oid  Wing 4 8  (47 -  
51)
XX, N one
6. F / 4 1 WHO 1 / Fibrous Parasagittal 46 XX, -22




46 XX, N one



















U n i v e r s i t y  o f  U t a h  I n s t i t u t i o n a l  R e p o s i t o r y
A u th o r  M a n u sc rip t
R a g e l  e t  a l. 41
P sam m om atou s ad d (6K a23). +7. +9. ad d (9 )(a 2 2 ). 
add(12W a13) [cd101
9. F / 4 9 WHO 1/  
Transitional
Posterior F o ssa









(+) E n tire  c h r o m o s o m e  a d d it io n , (-) e n t i re  c h r o m o s o m e  d e le t io n , (a d d )  p a r tia l 
c h r o m o s o m e  a d d itio n , (d e l) p a r tia l c h r o m o s o m e  d e le t io n .
G ie m s a - b a n d  k a ry o ty p in g  w a s  o b ta in e d  o n  8  m e n in g io m a s  g ro w n  in  v itro . M e n in g io m a s  
s tu d ie d  e x h ib ite d  a  n o rm a l k a ry o ty p e , a  s in g le  c h r o m o s o m a l  a b n o rm a lity ,  o r  m u ltip le  
c h r o m o s o m a l  a b n o rm a li t ie s .  T e x t in b o ld fa c e  ty p e  in d ic a te s  s im ila r  a b n o rm a li t ie s  
b e tw e e n  k a ry o ty p e d  m e n in g io m a s  u s e d  in th is  s tu d y . U n d e r lin e d  te x t  in d ic a te s  
m e n in g io m a  c h r o m o s o m a l  a b n o rm a li t ie s  r e p o r te d  in th e  l i te ra tu re . I ta lic ized  te x t 
in d ic a te s  s im ila r it ie s  b e tw e e n  th e  im m o rta l ce ll l in e s .



















T a b le  2 : Im m u n o re a c tiv ity  of m e n in g io m a  o p e r a t iv e  s p e c im e n s  a n d  tu m o r s  g ro w n  in th e  
m o u s e  f la n k s .
U n i v e r s i t y  o f  U t a h  I n s t i t u t i o n a l  R e p o s i t o r y
A u th o r  M a n u sc rip t
R a g e l  e t  a l. 4 2
lOMM-Lee C H -157 MN Pt. 3 Pt. 4 Pt. 5 Pt. 6 Pt. 7 Pt. 8
O perative
GFAP N/A N/A - - - - N.D. N.D.
Vimentin N/A N/A +++ +++ +++ ++ +++ +++
EMA N/A N/A + + + + - +
MIB-1 N/A N/A 5.7±4.1 1. 1±1.1 1 .9 ± 1 .3 13 .6± 6 .8 10 .2± 6 .2 18 .7± 4 .8
IVo u se
GFAP - - - - N.D. - N/A N/A
Vimentin + + + + N.D. + N/A N/A
EMA + + + + N.D. - N/A N/A
MIB-1 2 1 1 .0± 75 .7 1 9 0 .6 ± 2 3 .8 2 4 3 .9 ± 3 0 2 3 2 .7 ± 6 0 N.D. 0±0 N/A N/A
(N/A) N o t a p p l ic a b le ,  (N .D .) n o t d o n e ,  (++ +) s t ro n g , (++) m o d e ra te ,  (+) w e a k , (-) n o  
im m u n o h is to c h e m ic a l  s ta in in g .
MIB-1 c o u n ts  (m e a n  ± S D ).
